Abstract
The investigation of haemostasis is aimed to replicate normal blood coagulation in the laboratory. There are a number of different methods employed including clot-based coagulation tests, chromogenic assays, immunological tests, and aggregation studies. Today automated machines are designed to be able to perform a number of different methodologies.
To guarantee the results produced by a laboratory are reliable and accurate, laboratories need to follow international standards and guidelines and use established methodologies. The laboratory needs a quality management plan, to perform internal quality control and participate in an external quality assurance program.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McGlinchey K (2010) Coagulation automation. ADVANCE for Administrators of the Laboratory 19:26
Flanders MM, Crist R, Safapour S, Rodgers GM (2002) Evaluation and performance characteristics of the STA-R coagulation analyzer. Clin Chem 48:1622–1624
Milos M, Herak D, Kuric L, Horvat I, Zadro R (2007) Evaluation and performance characteristics of the coagulation system: ACL TOP analyzer—HemosIL reagents. Int J Lab Hematol 31:26–35
Kitchen S, McCraw A, on behalf of the WFH Laboratory Sciences Committee (2010) Diagnosis of haemophilia and other bleeding disorders: a laboratory manual, 2nd edn. World Federation of Hemophilia, Montreal, QC
Lind SE (1991) The bleeding time does not predict surgical bleeding. Blood 77:2547–2552
Mielke CH Jr, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI (1969) The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34:204–215
World Health Organisation (1997) Recommended methodology for using WHO International Preparations for thromboplastin, WHO, 1121 Geneva 27, Switzerland
Bai B, Christie DJ, Gorman RT, Wu JR (2008) Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory. Blood Coagul Fibrinolysis 19:569–576
D’Angelo A, Seveso MP, D’Angelo SV, Gilardoni F, Macagni A, Manotti C, Bonini P (1989) Comparison of two automated coagulometers and the manual tilt-tube method for the determination of prothrombin time. Am J Clin Pathol 92:321–328
Johnstone IB (1984) The activated partial thromboplastin time of diluted plasma: variability due to the method of fibrin detection. Can J Comp Med 48:198–201
Lippi G, Franchini M, Favaloro EJ (2009) One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin. Blood Coagul Fibrinolysis 20:1–3
Chandler WL, Ferrell C, Lee J, Tun T, Kha H (2003) Comparison of three methods for measuring factor VIII levels in plasma. Am J Clin Pathol 120:34–39
Keeling DM, Sukhu K, Kemball-Cook G, Waseem N, Bagnall R, Lloyd JV (1999) Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His 1954–> Leu substitution in the factor VIII A3 domain. Br J Haematol 105:1123–1126
Fareed J, Messmore HL, Walenga JM, Bermes EW Jr (1983) Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview. Clin Chem 29:225–236
Hutton RA (1987) Chromogenic substrates in haemostasis. Blood Rev 1:201–206
Svendsen L, Blomback B, Blomback M, Olson PI (1972) Synthetic chromogenic substrates for determination of trypsin, thrombin and thrombin-like enzymes. Thromb Res 1:267–278
Francis JL (1979) A new chromogenic assay for the specific determination of prothrombin. J Clin Pathol 32:651–654
Tripodi A, Mannucci PM (1984) Clinical evaluation of a fully automated chromogenic method for prothrombin time compared with a conventional coagulation method. Clin Chem 30:1392–1395
Girolami A, Vettore S (2009) Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many. Blood Coagul Fibrinolysis 20:484–485
Peyvandi F, Menegatti M, Santagostino E, Akhavan S, Uprichard J, Perry DJ, Perkins SJ, Mannucci PM (2002) Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 117:685–692
Walker JM (ed) (1996) The protein protocols handbook. Humana, Totowa, NJ
Palareti G, Maccaferri M, Manotti C, Tripodi A, Chantarangkul V, Rodeghiero F, Ruggeri M, Mannucci PM (1991) Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio. Clin Chem 37:714–719
Verbruggen (1975) Quantitative immunoelectrophoretic methods: a literature survey. Clin Chem 21:5–43
Ruggeri ZM, Zimmerman TS (1981) The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140–1143
Engvall E (2010) The ELISA, enzyme-linked immunosorbent assay. Clin Chem 56:319–320
Voller A, Bartlett A, Bidwell DE (1978) Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol 31:507–520
Amiral J, Adalbert B, Adam M (1984) Application of enzyme immunoassays to coagulation testing. Clin Chem 30:1512–1516
van der Graaf F, van den Borne H, van der Kolk M, de Wild PJ, Janssen GW, van Uum SH (2000) Exclusion of deep venous thrombosis with D-dimer testing—comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 83:191–198
Pengo V, Thiagarajan P, Shapiro SS, Heine MJ (1987) Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 70:69–76
Gella FS, Gener J, Latex J (1991) Agglutination procedures in immunodiagnosis. Pure Appl Chem 63:1131–1134
Ewenstein BM (2001) Use of ristocetin cofactor activity in the management of von Willebrand disease. Haemophilia 7(Suppl 1):10–15
Lewis SM, Bain BJ, Bates I (eds) (2006) Dacie and Lewis practical haematology, 10th edn. Churchill Livingstone Elsevier, Philadelphia, PA
Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J (1973) Quantitative assay of a plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 52:2708–2716
Born GV, Cross MJ (1963) The aggregation of blood platelets. J Physiol 168:178–195
Yardumian DA, Mackie IJ, Machin SJ (1986) Laboratory investigation of platelet function: a review of methodology. J Clin Pathol 39:701–712
British Committee for Standards in Haematology (1988) Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force, 1988/12/01 ed, p 1322–1330, J Clin Pathol
National Pathology Accreditation Advisory Council (2009) Requirements for participation in external quality assessment, Commonwealth of Australia
World Health Organisation (2011) International reference materials. www.who.int/bloodproducts/ref_materials/en/
Hubbard AR, Kitchen S, Beeharry M, Bevan SA, Bowyer A, on behalf of the SSC Working Group on Coagulation Standards of the ISTH. (2011) Long-term stability of the Scientific and Standardization Committee Secondary Coagulation Standard (SSC Lot no. 3). J Thromb Haemost 9:2146–2148
Clinical Laboratory Standards Institute (2011) Working together to improve the quality of medical care–the Global Application of CLSI Documents, Lab Medicine, p 440–441
Lewis SM (1988) The WHO international external quality assessment scheme for haematology. Bull World Health Organ 66:283–290
Lewis SM (1996) Quality control: good laboratory practice—an overview of quality assurance. In: XXVIth World Congress of the International Society of Haematology. ICSH, Singapore
Garvey MB, Black JM (1972) The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle. J Clin Pathol 25:680–682
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this protocol
Cite this protocol
Crighton, G. (2013). Methods of Coagulation. In: Monagle, P. (eds) Haemostasis. Methods in Molecular Biology, vol 992. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-339-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-339-8_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-338-1
Online ISBN: 978-1-62703-339-8
eBook Packages: Springer Protocols